Ravishankar Asokkumar

Ravishankar Asokkumar

Auto-generated profile, based on publicly available information

Ravishankar Asokkumar

Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
GLGontrand Lopez-Nava
Gontrand Lopez-Nava
ANAnuradha Negi
Anuradha Negi
IBInmaculada Bautista-Castaño
Inmaculada Bautista-Castaño
MRMiguel Angel Rubio
Miguel Angel Rubio
RARavishankar Asokkumar
Ravishankar Asokkumar

19 October 2023 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
DLDaniel Yan Zheng Lim
Daniel Yan Zheng Lim
YTYu Bin Tan
Yu Bin Tan
JKJonathan Tian En Koh
Jonathan Tian En Koh
JTJoshua Yi Min Tung
Joshua Yi Min Tung
GSGerald Gui Ren Sng
Gerald Gui Ren Sng
CTChee‐Kiat Tan
Chee‐Kiat Tan

22 July 2020 in Endoscopy
Verified
Journal Article
Closed access
PDF file
GLGontrand Lopez-Nava
Gontrand Lopez-Nava
RARavishankar Asokkumar
Ravishankar Asokkumar
IBInmaculada Bautista-Castaño
Inmaculada Bautista-Castaño
JLJanese Laster
Janese Laster
ANAnuradha Negi
Anuradha Negi
AGAmador Garcia Ruiz de Gordejuela
Amador Garcia Ruiz de Gordejuela
Background Endoscopic sleeve gastroplasty (ESG) is an effective treatment option for obesity. However, data comparing its efficacy to bariatric surgery are scarce. We aimed to compare the effectiveness and safety of ESG with laparoscopic sleeve gastrectomy (LSG) and laparoscopic greater curve plication (LGCP) at 2 years. Methods We reviewed 353 patient records and identified 296 patients who underwent ESG (n = 199), LSG (n = 61), and LGCP (n = 36) at four centers in Spain between 2014 and 2016. We compared their total body weight loss (%TBWL) and safety over 2 years. A linear mixed model (LMM) was used to analyze repeated measures of weight loss outcomes at 6, 12, 18, and 24 months to compare the three procedures. Results Among the 296 patients, 210 (ESG 135, LSG 43, LGCP 32) completed 1 year of follow-up and 102 (ESG 46, LSG 34, LGCP 22) reached 2 years. Their mean (standard deviation [SD]) body mass index (BMI) was 39.6 (4.8) kg/m2. There were no differences in age, sex, or BMI between the groups. In LMM analysis, adjusting for age, sex, and initial BMI, we found ESG had a significantly lower TBWL, %TBWL, and BMI decline compared with LSG and LGCP at all time points (P = 0.001). The adjusted mean %TBWL at 2 years for ESG, LSG, and LGCP were 18.5 %, 28.3 %, and 26.9 %, respectively. However, ESG, when compared with LSG and LGCP, had a shorter inpatient stay (1 vs. 3 vs. 3 days; P < 0.001) and lower complication rate (0.5 % vs. 4.9 % vs. 8.3 %; P = 0.006). Conclusion All three procedures induced significant weight loss in obese patients. Although the weight loss was lower with ESG compared with other techniques, it displayed a better safety profile and shorter hospital stay.

25 November 2019 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
GLGontrand Lopez-Nava
Gontrand Lopez-Nava
RARavishankar Asokkumar
Ravishankar Asokkumar
ARAngel Rull
Angel Rull
FCFernandez Corbelle
Fernandez Corbelle
LGLucía Beltrán Garrayo
Lucía Beltrán Garrayo
IBInmaculada Bautista
Inmaculada Bautista
Background and study aims It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT follow-up than by procedure type. We aimed to compare 1 year weight loss outcomes of four different EBTs at a single center with a standardized MDT follow-up. Patients and methods We prospectively collected and retrospectively analyzed outcomes in 962 patients (female-691, 71.2 %; mean age, 44.8 ± 10.6 years, mean BMI, 37.8 ± 5.9 Kg/m2) treated with Intragastric balloons (IGBs) or endoscopic gastroplasty (EG) at HM Sanchinarro University Hospital between March 2012 to January 2017. The procedures were performed by the same endoscopist and followed up by the same MDT. We compared the percentage total body weight loss (%TWBL) at 1 year. We performed linear and logistic regression to identify predictive factors for weight loss and follow-up adherence at 1 year. Results Four hundred and eighty-one IGBs (Orbera-80.9 %; ReShape Duo-19.1 %), and 481 EG (Apollo ESG-51.3 %; Primary obesity surgery endoluminal-POSE-48.6 %) were performed. Only 480 patients (IGB- 45 %; EG- 55 %) completed 1 year follow-up. Among them, Apollo ESG achieved significantly higher TBWL (19.5 ± 13 %, P = 0.035), %TBWL (17.4 ± 10.2 %, P = 0.025), and ≥ 20 % TBWL (36.7 %, P = 0.032). However, in linear regression after adjusting for variables, only higher initial BMI (B = 0.31, P < 0.001) and higher percentage follow-up attendance (B = 0.24, P < 0.001) significantly predicted %TBWL at 1 year in the completion group but not the procedure type (B = 0.02, P = 0.72). In logistic regression, we observed female sex (P = 0.01), high initial BMI (P < 0.001), endoscopic gastroplasty (P = 0.04), and high 1-month %TBWL (P < 0.001) significantly predicted follow-up completion at 1 year. Conclusions Weight loss at 1 year is dependent on MDT follow-up rather than procedure type. Endoscopic gastroplasty promoted follow-up adherence more than IGBs. * Drs. Lopez-Nava and Asokkumar: These authors contributed equally.

24 June 2020 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
GLGontrand Lopez-Nava
Gontrand Lopez-Nava
RARavishankar Asokkumar
Ravishankar Asokkumar
ANAnuradha Negi
Anuradha Negi
ENEnrique Normand
Enrique Normand
IBInmaculada Bautista
Inmaculada Bautista

25 January 2021 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
GLGontrand Lopez-Nava
Gontrand Lopez-Nava
JLJanese Laster
Janese Laster
ANAnuradha Negi
Anuradha Negi
SFStephanie Fook-Chong
Stephanie Fook-Chong
IBI. Bautista-Castaño
I. Bautista-Castaño
RARavishankar Asokkumar
Ravishankar Asokkumar